Literature DB >> 11131105

Fibrinogen, other cardiovascular risk factors and diabetes mellitus in Hong Kong: a community with high prevalence of Type 2 diabetes mellitus and impaired glucose tolerance.

T H Lam1, L J Liu, E D Janus, K S Lam, A J Hedley.   

Abstract

AIMS: To determine the prevalence of Type 2 diabetes mellitus and impaired glucose tolerance (IGT) and their relationships to fibrinogen and other cardiovascular risk factors in Hong Kong Chinese.
METHODS: A probability sample of 1,316 men and 1,348 women aged 25-74 years were examined in a population-based cross-sectional study.
RESULTS: A total of 3.0% (95% confidence interval 2.1-3.9) of men had previously diagnosed (known) and 6.4% (5.0-7.8) newly diagnosed (unknown) diabetes, 14.4% (12.4-16.5) had IGT and 79.2% were normal by 1985 WHO diagnostic criteria; corresponding prevalences in women were 3.7% (2.7-4.7), 5.9% (4.6-7.2), 17% (14.8-19.2) and 73.4%. The age-standardized prevalence of Type 2 diabetes for the 35-64 age group was 9.5% (7.5-11.6) in men and 10.2% (8.0-12.4) in women. Age-adjusted mean fibrinogen levels in these four groups (normal/IGT/unknown diabetes/known diabetes) with decreasing degrees of glucose tolerance (diabetes status) were 2.80, 2.57, 2.51 and 2.47 g/l (P = 0.003) in men, and 2.86, 2.72, 2.67, 2.61 g/l (P = 0.005) in women. Age, obesity, systolic blood pressure and triglycerides were significantly associated with diabetes status in both sexes, fibrinogen in men only and high density lipoprotein cholesterol negatively in women.
CONCLUSIONS: The prevalence of Type 2 diabetes mellitus was very high especially in older subjects, and fibrinogen was associated with increasing glucose intolerance in men but not in women. The detection and better control of cardiovascular risk factors, particularly hypertension in this developed Chinese community with a high prevalence of diabetes and glucose intolerance, is particularly important.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11131105     DOI: 10.1046/j.1464-5491.2000.00384.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  8 in total

1.  Improved fibrinolysis by an intensive lifestyle intervention in subjects with impaired glucose tolerance. The Finnish Diabetes Prevention Study.

Authors:  H Hämäläinen; T Rönnemaa; A Virtanen; J Lindström; J G Eriksson; T T Valle; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; M Rastas; S Aunola; M Uusitupa; J Tuomilehto
Journal:  Diabetologia       Date:  2005-10-05       Impact factor: 10.122

2.  Overweight, family history of diabetes and attending schools of lower academic grading are independent predictors for metabolic syndrome in Hong Kong Chinese adolescents.

Authors:  Risa Ozaki; Qing Qiao; Gary W K Wong; Michael H M Chan; Wing-Yee So; Peter C Y Tong; C S Ho; Gary Tin-Choi Ko; Alice P S Kong; Christopher W K Lam; Jaakko Tuomilehto; Juliana C N Chan
Journal:  Arch Dis Child       Date:  2006-11-06       Impact factor: 3.791

3.  Plasma fibrinogen level: an independent risk factor for long-term survival in Chinese patients with peripheral artery disease?

Authors:  Bernice L Y Cheuk; Grace C Y Cheung; Silvana S F Lau; Stephen W K Cheng
Journal:  World J Surg       Date:  2005-10       Impact factor: 3.282

Review 4.  Lessons learned from young-onset diabetes in China.

Authors:  Juliana C N Chan; Maggie C Y Ng
Journal:  Curr Diab Rep       Date:  2003-04       Impact factor: 5.430

5.  Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study.

Authors:  E Imai; J C N Chan; S Ito; T Yamasaki; F Kobayashi; M Haneda; H Makino
Journal:  Diabetologia       Date:  2011-10-13       Impact factor: 10.122

6.  Diabetes mellitus and periodontal disease: awareness and practice among doctors working in public general out-patient clinics in Kowloon West Cluster of Hong Kong.

Authors:  Sut Yee Tse
Journal:  BMC Fam Pract       Date:  2018-12-17       Impact factor: 2.497

7.  Influence of fibrinogen and C-RP on progression of peripheral arterial disease in type 2 diabetes: a preliminary report.

Authors:  Marijan Bosevski; Golubinka Bosevska; Lily Stojanovska
Journal:  Cardiovasc Diabetol       Date:  2013-02-01       Impact factor: 9.951

8.  An evaluation of glucose tolerance in essential hypertension.

Authors:  Armagan Tugrul; Sibel Guldiken; Betul Ugur-Altun; Ender Arikan
Journal:  Yonsei Med J       Date:  2009-04-30       Impact factor: 2.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.